Current pharmacotherapy of overactive bladder
Int. braz. j. urol
;
47(6): 1091-1107, Nov.-Dec. 2021. tab
Article
in English
| LILACS
| ID: biblio-1340029
ABSTRACT
ABSTRACT Overactive bladder is a symptom complex consisting of bothersome storage urinary symptoms that is highly prevalent among both sexes and has a significant impact on quality of life. Various antimuscarinic agents and the beta-3 agonists mirabegron and vibegron are currently available for the treatment of OAB. Each drug has specific pharmacologic properties, dosing schedule and tolerability profile, making it essential to individualize the medical treatment for the patient's characteristics and expectations. In this manuscript, we review the most important factors involved in the contemporary pharmacological treatment of OAB.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Urinary Bladder, Overactive
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Int. braz. j. urol
Journal subject:
Urology
Year:
2021
Type:
Article
Affiliation country:
Brazil
/
Portugal
/
United States
Institution/Affiliation country:
Faculdade de Medicina da Universidade de São Paulo/BR
/
Faculdade de Medicina do Porto/PT
/
University of Southern California/US
Similar
MEDLINE
...
LILACS
LIS